Esperion Therapeutics, Inc.
Key Metrics
- Previous Close
- —
- 52-Week Range
- —
- Market Cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Dividend Yield
- —
Advanced Metrics
- Price/Book
- —
- PEG Ratio
- —
- Return on Equity
- —
- Return on Assets
- —
- Gross Margin
- —
- Operating Margin
- —
- Profit Margin
- —
- Current Ratio
- —
- Debt/Equity
- —
- Total Debt
- —
- Free Cash Flow
- —
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- —
Market Snapshot
About
Esperion Therapeutics, Inc. is a pharmaceutical company focused on developing and commercializing therapies for patients with elevated low-density lipoprotein cholesterol (LDL-C). The company has developed oral non-statin LDL-C lowering medicines for patients who cannot achieve their cholesterol goals with statins alone or who are statin-intolerant. Esperion's commercial products provide additional treatment options for managing cardiovascular risk through lipid modification. The company continues to conduct clinical research to expand approved indications and develop next-generation cardiovascular therapies.